Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

Saydam G., Haznedaroglu I., Kaynar L., Yavuz A., Ali R., Guvenc B., ...Daha Fazla

Hematology (Amsterdam, Netherlands), ss.1-7, 2018 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası:
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1080/10245332.2018.1444919
  • Dergi Adı: Hematology (Amsterdam, Netherlands)
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1-7
  • Anahtar Kelimeler: BCR-ABL1, chronic myeloid leukemia, molecular response, nilotinib, tyrosine kinase inhibitor, TREATMENT-FREE REMISSION, DIAGNOSED CHRONIC-PHASE, MOLECULAR RESPONSE, IMATINIB, CYTARABINE, INTERFERON, OUTCOMES
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır